The following are some of the biotech companies that reported quarterly results and provided an update on their pipeline progress on Thursday.
1. Aerie Pharmaceuticals Inc. (AERI) expects to initiate a phase III registrational study for AR-15512 in dry eye during the second quarter of 2022.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.